Table 1 Summarizes the participants’ demographic and clinical characteristics
From: Early predictors of new-onset immune-related seizures: a preliminary study
AE | Non-AE | P values | |
|---|---|---|---|
Sample size | 23(14.9%) | 131(85.1%) | |
Age of onset(year) | <0.01 | ||
<16 | 0/23(0%) | 58/131(36.7%) | |
≥ 16 | 23/23(100%) | 73/131(47.4%) | |
Sex | 0.294 | ||
Male | 12/23(52.2%) | 53/131(40.4%) | |
Female | 11/23(47.8%) | 78/131(59.6%) | |
APE2 | <0.01 | ||
<4 | 6/23(26.1%) | 131/131(100%) | |
≥ 4 | 17/23(73.9%) | 0/131(0%) | |
NSAbs | |||
Total | 21 | 13 | <0.01 |
NMDAR | 9/21(42.9%) | 7/13(53.8%) | |
GABABR | 3/21(14.3%) | 1/13(15.4%) | |
LGI1 | 5/21(23.8%) | 3/13(23.1%) | |
CASPR2 | 3/21(14.3%) | 2/13(7.7%) | |
NMDAR/CASPR2 | 1/21(4.7%) | 0/13(0%) |